PICC Placement for Peripheral Catheterization in Newborns
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What data supports the effectiveness of the treatment Peripherally Inserted Central Venous Catheter (PICC) in newborns?
Is PICC placement safe for newborns?
PICC placement in newborns is generally considered safe, but there are some risks of complications. Studies show that complications can include mechanical issues like accidental removal or obstruction, and infections, with an overall complication rate of around 18.7% in pediatric cases. Proper management by the healthcare team can help reduce these risks.36789
How does the PICC treatment for newborns differ from other treatments?
The PICC (Peripherally Inserted Central Venous Catheter) treatment is unique because it involves inserting a thin, flexible tube into a vein in the arm or leg and threading it to a large vein near the heart, allowing for long-term intravenous access. This method is less invasive than traditional central venous catheters, which require insertion into larger veins in the neck or chest, making it particularly suitable for delicate newborns.1011121314
What is the purpose of this trial?
This study examines whether there is an association between the PICC insertion site and the complications necessitating PICC removal in neonates admitted to neonatal intensive care unit.
Research Team
Amuchou Soraisham, MD
Principal Investigator
University of Calgary
Eligibility Criteria
This trial is for newborns of any gestational age in the NICU at Foothills Medical Centre and Alberta Children's Hospital who need a PICC line as part of their care. They must have available veins for insertion both above and below the umbilicus.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
PICC lines are inserted in either the upper or lower extremity of neonates and monitored for complications
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Peripherally Inserted Central Venous Cather (PICC)
Peripherally Inserted Central Venous Cather (PICC) is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Long-term IV medication administration
- Total parenteral nutrition
- Blood product infusions
- Frequent blood draws
- IV infusion of irritant medications
- Long-term administration of medications
- Monitoring of interventions
- Patients with poor peripheral access
- Long-term IV therapy
- Total parenteral nutrition
- Blood product infusions
- Frequent blood draws
- Long-term IV medication administration
- Total parenteral nutrition
- Blood product infusions
- Frequent blood draws
- Long-term IV therapy
- Total parenteral nutrition
- Blood product infusions
- Frequent blood draws
- Long-term IV medication administration
- Total parenteral nutrition
- Blood product infusions
- Frequent blood draws
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor